FDA Import Refusal AEK-7499879-7/31/1 — Serdia Pharmaceuticals (India)
The FDA refused shipment AEK-7499879-7/31/1 from Serdia Pharmaceuticals (India) (India) on Jun 19, 2020. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 19, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75